Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer

Tamoxifen (TAM), a selective estrogen receptor modulator, is often used for long-term adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer. TAM is known to increase the risk of endometrial cancer (EC); however, the mechanism has not yet been fully elucidated. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Harumi, Horimoto, Yoshiya, Hlaing, May Thinzar, Men, Yuan, Rong, Lu, Ishizuka, Yumiko, Uomori, Toshitaka, Yoshida, Emiko, Terao, Yasuhisa, Arakawa, Atsushi, Saito, Tsuyoshi, Yao, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688500/
https://www.ncbi.nlm.nih.gov/pubmed/38034487
http://dx.doi.org/10.3892/ol.2023.14142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688500/
https://www.ncbi.nlm.nih.gov/pubmed/38034487
http://dx.doi.org/10.3892/ol.2023.14142

Ejemplares similares